Literature DB >> 14672354

Bone histomorphometric changes after liver transplantation for chronic cholestatic liver disease.

Maureen M J Guichelaar1, Michael Malinchoc, Jean D Sibonga, Bart L Clarke, J Eileen Hay.   

Abstract

UNLABELLED: Thirty-three patients with cholestatic liver disease underwent histomorphometric assessment of paired bone biopsy specimens at time of orthotopic liver transplantation (OLT) and 4 months thereafter. At 4 months after OLT, bone metabolism improved, with bone formation increasing to normal and no change in bone resorption. Early post-transplant bone loss may be attributed to an additional insult to bone formation early after transplantation.
INTRODUCTION: Patients with advanced liver disease, especially chronic cholestasis, often have osteopenia, which worsens early after orthotopic liver transplantation (OLT) before starting to recover. The changes in bone metabolism leading to this rapid loss of bone after OLT, and to its recovery, are poorly defined.
MATERIALS AND METHODS: In thirty-three patients with advanced chronic cholestatic liver disease, tetracycline-labeled bone biopsy specimens were analyzed prospectively at time of OLT and at 4 months after OLT, as part of a randomized trial to study the efficacy of calcitonin on post-transplant bone loss. Hierarchical cluster analysis of histomorphometric parameters was performed in an attempt to establish the functional grouping of individual histomorphometric parameters before and after OLT. RESULTS AND
CONCLUSIONS: Results showed that from the time of OLT to 4 months after OLT, bone mineral density of the lumbar spine and histomorphometric parameters of bone volume decreased, consistent with early post-transplant bone loss. Histomorphometric resorption parameters were increased before OLT, with no change after OLT. Histomorphometric formation parameters increased from low values before OLT to normal values at 4 months after OLT, with the exception of mean wall thickness values, which further decreased after OLT, suggesting an additional insult to bone formation during the study period. Histomorphometric changes after OLT were similar in female and male patients, pre- and postmenopausal women, and in patients treated and not treated with calcitonin. Hierarchical cluster analysis suggested that before OLT, bone resorption was functioning independently of bone formation, but that by 4 months after OLT, their coupled relationship had improved. Therefore, despite post-transplant bone loss, by 4 months after OLT, bone metabolism had improved, with increased bone formation and more coupled bone balance, as suggested by hierarchical cluster analysis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14672354     DOI: 10.1359/jbmr.2003.18.12.2190

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  8 in total

1.  Total 25(OH) vitamin D, free 25(OH) vitamin D and markers of bone turnover in cirrhotics with and without synthetic dysfunction.

Authors:  Jennifer C Lai; Daniel D Bikle; Blanca Lizaola; Hilary Hayssen; Norah A Terrault; Janice B Schwartz
Journal:  Liver Int       Date:  2015-03-27       Impact factor: 5.828

2.  Bone Density in Children With Chronic Liver Disease Correlates With Growth and Cholestasis.

Authors:  Kathleen M Loomes; Cathie Spino; Nathan P Goodrich; Thomas N Hangartner; Amanda E Marker; James E Heubi; Binita M Kamath; Benjamin L Shneider; Philip Rosenthal; Paula M Hertel; Saul J Karpen; Jean P Molleston; Karen F Murray; Kathleen B Schwarz; Robert H Squires; Jeffrey Teckman; Yumirle P Turmelle; Estella M Alonso; Averell H Sherker; John C Magee; Ronald J Sokol
Journal:  Hepatology       Date:  2018-12-27       Impact factor: 17.425

3.  Bone mineral density in children with cirrhosis.

Authors:  Nuray Uslu; Inci Nur Saltik-Temizel; Hülya Demir; Yusuf Usta; Hasan Ozen; Figen Gürakan; Aysel Yüce; Nurten Koçak
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

4.  Treatment of osteoporosis in patients with chronic liver disease and in liver transplant recipients.

Authors:  Naim M Maalouf; Khashayar Sakhaee
Journal:  Curr Treat Options Gastroenterol       Date:  2006

5.  The role of mast cells in parathyroid bone disease.

Authors:  Russell T Turner; Urszula T Iwaniec; Kevin Marley; Jean D Sibonga
Journal:  J Bone Miner Res       Date:  2010-07       Impact factor: 6.741

Review 6.  Bone Diseases in Patients with Chronic Liver Disease.

Authors:  Hae Min Jeong; Dong Joon Kim
Journal:  Int J Mol Sci       Date:  2019-08-31       Impact factor: 5.923

Review 7.  Osteoporosis in Primary Biliary Cholangitis: Prevalence, Impact and Management Challenges.

Authors:  Hirsh D Trivedi; Christopher J Danford; Daniela Goyes; Alan Bonder
Journal:  Clin Exp Gastroenterol       Date:  2020-01-15

Review 8.  Pretransplant Evaluation and Liver Transplantation Outcome in PBC Patients.

Authors:  Maja Mijic; Ivona Saric; Bozena Delija; Milos Lalovac; Nikola Sobocan; Eva Radetic; Dora Martincevic; Tajana Filipec Kanizaj
Journal:  Can J Gastroenterol Hepatol       Date:  2022-07-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.